” Selling pharmaceuticals is an extremely competitive business and companies know that they need to put their best face forward. That face is usually a smiling drug representative whose job it is to teach your physician about the newest medicines being produced today.
In Canada the drug industry spends roughly $3 billion per year marketing its products, two-thirds of which goes towards the salaries of the sales reps who visit our physicians regularly, and the drug samples they use to enhance their one-on-one learning sessions. “
” Here are six new Pharma marketing initiatives that are guaranteed to keep investor expectations high along with our insurance premiums. The secret? Recycling old and discredited drugs and marketing diseases to sell the few new ones. ‘
” There is good news and bad news about attention deficit/hyperactivity disorder (ADHD) — that is, if you’re a drug company. The bad news is the kid market has peaked out with 4.5 million U.S. children now carrying the label. The good news is adult ADHD is an emerging market. In fact, adult ADHD, with symptoms similar to pediatric ADHD such as impulsivity, distractibility and difficulty paying attention, following instructions and meeting deadlines, is the next big thing “.
” … When a company’s patent on a brand-name drug expires, other companies are free to make generic versions of the same drug… Often times, there are legal disputes between brand-name drug manufacturers and generic-drug companies. It’s increasingly common for this litigation to end with out-of-court settlements in which patentholders pay potential competitors to delay the introduction of generics.
That’s pay-to-delay… ”
More transparency on doctors’ lucrative industry ties?
” This month American regulators released rules to implement a so-called Sunshine law designed to improve transparency. France passed a similar law in 2011. Firms in Britain are planning voluntary disclosures. By 2015 more than 70% of drug sales will be in countries with such measures, according to Deloitte, a consultancy. ”
Read New efforts to reveal the ties between doctors and drug firms : Let the sunshine in, Mar 2nd 2013.
Feds to Publicize Drug and Device Company Payments to Doctors Next Year
” After years of anticipation, all of the nation’s drug and medical device makers must soon begin publicly reporting payments they make to U.S. physicians, according to final regulations announced this month by the federal government. ”
Drugmakers once touted nerve growth factor inhibitors as a potential breakthrough
The power of big pharma and big money!
Drug makers often abandon research on experimental drugs that appear to have safety issues but with more than 50 million U.S. adults diagnosed with arthritis the potential multibillion dollar market opportunity may be too big to ignore …
Here we go again !!!